Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview

Author： Semeraro Francesco   Morescalchi Francesco   Duse Sarah   Gambicorti Elena   Romano Mario R   Costagliola Ciro  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.6, 2014-06, pp. : 785-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-01 ,pp. : 173-181

Bentham Science Publishers

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew   Kaiser Peter K  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

By Barakat Mark Rami   Kaiser PK  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey   Mrejen Sarah   Gallego-Pinazo Roberto  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V.   Kaiser Peter K.  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite